Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials — Stephen P. McKenna (2003) | RDL Network
Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials
Article 2003 en
Authors
SM
Stephen P. McKenna
SC
Sharon A. Cook
DW
D Whalley
Abstract
1 min read
The PSORIQoL appears to be a practical, reliable and valid instrument for measuring the impact of psoriasis on QoL. It remains necessary to establish the instrument's responsiveness to changes in QoL associated with treatment.
Christopher Em Griffiths, Seong Jin Jo, Luigi Naldi, Ricardo Romiti, Esther Guevara‐Sanginés, T Howe, G. Pietri, I. Gilloteau, Craig Richardson, Hongqing Tian, Matthias Augustin
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.